Navigation Links
Tracking down the origin of leukemia relapse
Date:4/4/2011

The cancer cells that reign during relapses of an aggressive human leukemia are different from those that dominated the original disease, according to a paper published online on April 4 in the Journal of Experimental Medicine (www.jem.org).

By comparing the DNA of cancer cells taken at the time of diagnosis and relapse from patients with T cell acute lymphoblastic leukemia (T-ALL), Jean Soulier and co-workers found that the relapse cells arose from cells that were scarce at the time of diagnosis. The relapse cells had also picked up several new and dangerous mutations. Mimicking these mutations in cells isolated at diagnosis rendered them more cancerous after injection into immune-depleted mice.

Untouched cancer cells from diagnosis samples also caused leukemia when injected into mice. And once established, they bore a closer genetic resemblance to relapse cells than to their former selves, suggesting that the most aggressive cancer cells prevail in both mouse and man.

These findings suggest that tracking human leukemia development in immune-depleted mice might provide insight into the mechanisms underlying relapses of the human disease.


'/>"/>

Contact: Rita Sullivan
news@rupress.org
212-327-8603
Rockefeller University Press
Source:Eurekalert

Page: 1

Related medicine news :

1. Tracking down particulates
2. Tracking PSA Test Results Over Time Gives Clues to Cancer
3. Color-coded tracking method helps scientists analyze outcomes of newly transplanted tissue
4. Life Science Contract Manufacturing Gains Predictable On-Time Production with TraceLink's Production Tracking Solution
5. USPack Courier Brings Tracking Precision to Medical and Blood Shipments
6. Newest Release of FileTrail Sets New Standard in Global Physical Records Management and File Tracking
7. TalentWise Integrates Employment Screening with Leading Applicant Tracking Solution for Healthcare Industry TalentWise becomes HealthcareSource Certified Integration Partner For Position Manager Product
8. COO Becomes 75% More Effective in Tracking Delegated Tasks
9. Tickerspy.com Announces New Stock Index Tracking Chinese Healthcare Stocks
10. Massive Food Flavoring Recall Underscores Need for New Tracking Technology to Contain Outbreaks of Foodborne Illness
11. The Pediatric Dengue Vaccine Initiative Introduces www.DengueWatch.org - a News hub for Tracking Dengue Fever Epidemics Worldwide
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/17/2017)... ... January 17, 2017 , ... ... companies and ranked among the top US security companies for consecutive years, today ... This announcement brings a year-long independent board nomination process to a close and ...
(Date:1/17/2017)... (PRWEB) , ... January 17, 2017 , ... ... Center and the Montclair State University’s Athletic Training Education program forged a relationship ... Athletic Training Education Program, which is consists of both student members and ...
(Date:1/16/2017)... ... ... California Southern University has named Dr. Steven Beazley University President. ... a core faculty member, teaching master’s and doctoral courses in the university’s School of ... where he earned his Doctor of Psychology degree in 1998. Dr. Beazley also has ...
(Date:1/16/2017)... ... January 16, 2017 , ... With the Grand Opening Event planned for ... use by sports teams and the general public. Built in five months by Centerpoint, ... be converted into basketball or pickleball courts. The space is also suitable for indoor ...
(Date:1/16/2017)... ... January 16, 2017 , ... As New York’s ... Victor Giamos, MD to their medical staff, according to eye surgeon, Jeffrey Martin, ... Eye Care, a division of SightMD. Dr. Giamos will practice primarily out of ...
Breaking Medicine News(10 mins):
(Date:1/17/2017)... Calif. and KANSAS CITY, ... Children,s Hospitals Neonatal Consortium (CHNC) has selected Velos ... their visionary data management and multicenter initiatives. ... organization comprised of 32 Neonatal Intensive Care Units ... America . The consortium provides a benchmark ...
(Date:1/17/2017)... , Jan. 17, 2016  Attorney Advertising -- Bronstein, Gewirtz ... purchasers of Anthera Pharmaceuticals, Inc. ("Anthera" or the "Company") (NASDAQ: ... additional information and assist the investigation by visiting the firm,s ... Anthera and certain of its officers and/or directors have violated ... 1934. ...
(Date:1/17/2017)...   Tocagen Inc ., a clinical-stage, cancer-selective gene therapy company, ... research and pharmaceutical development at Tocagen, will present at Phacilitate ... 17-20 in Miami . Details ... ... replicating viruses - what to do when and why Date and ...
Breaking Medicine Technology: